

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | establishment of integrated proviral latency (GO:0075713) | 5.26758630 |
| 2 | negative regulation of fibrinolysis (GO:0051918) | 5.21713516 |
| 3 | ribosome assembly (GO:0042255) | 4.86166190 |
| 4 | regulation of fibrinolysis (GO:0051917) | 4.45017016 |
| 5 | DNA topological change (GO:0006265) | 4.32697648 |
| 6 | DNA unwinding involved in DNA replication (GO:0006268) | 4.24196960 |
| 7 | establishment of viral latency (GO:0019043) | 4.17967783 |
| 8 | blood coagulation, intrinsic pathway (GO:0007597) | 4.15727843 |
| 9 | DNA ligation (GO:0006266) | 3.92101679 |
| 10 | CENP-A containing nucleosome assembly (GO:0034080) | 3.87933156 |
| 11 | regulation of transcription from RNA polymerase I promoter (GO:0006356) | 3.86682401 |
| 12 | formation of translation preinitiation complex (GO:0001731) | 3.84275724 |
| 13 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.75070047 |
| 14 | chromatin remodeling at centromere (GO:0031055) | 3.72702688 |
| 15 | cholesterol biosynthetic process (GO:0006695) | 3.72256644 |
| 16 | L-phenylalanine metabolic process (GO:0006558) | 3.46870356 |
| 17 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.46870356 |
| 18 | proteasome assembly (GO:0043248) | 3.45464612 |
| 19 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.42190315 |
| 20 | L-phenylalanine catabolic process (GO:0006559) | 3.42190315 |
| 21 | fibrinolysis (GO:0042730) | 3.39274063 |
| 22 | membrane budding (GO:0006900) | 3.33097832 |
| 23 | mitotic metaphase plate congression (GO:0007080) | 3.31844649 |
| 24 | histone exchange (GO:0043486) | 3.30106927 |
| 25 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.26873599 |
| 26 | polyketide metabolic process (GO:0030638) | 3.25820420 |
| 27 | doxorubicin metabolic process (GO:0044598) | 3.25820420 |
| 28 | daunorubicin metabolic process (GO:0044597) | 3.25820420 |
| 29 | sterol biosynthetic process (GO:0016126) | 3.25657483 |
| 30 | alpha-linolenic acid metabolic process (GO:0036109) | 3.24549330 |
| 31 | protein localization to kinetochore (GO:0034501) | 3.18793688 |
| 32 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.18788363 |
| 33 | plasma lipoprotein particle assembly (GO:0034377) | 3.17949368 |
| 34 | DNA replication-independent nucleosome organization (GO:0034724) | 3.17140985 |
| 35 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.17140985 |
| 36 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.14283862 |
| 37 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.14283862 |
| 38 | regulation of protein activation cascade (GO:2000257) | 3.13263268 |
| 39 | NADPH regeneration (GO:0006740) | 3.13137274 |
| 40 | regulation of cholesterol esterification (GO:0010872) | 3.10732431 |
| 41 | protein carboxylation (GO:0018214) | 3.10396178 |
| 42 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.10396178 |
| 43 | purine nucleobase biosynthetic process (GO:0009113) | 3.10366492 |
| 44 | organelle disassembly (GO:1903008) | 3.10361711 |
| 45 | DNA strand elongation (GO:0022616) | 3.05640097 |
| 46 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.05327544 |
| 47 | glyoxylate metabolic process (GO:0046487) | 3.01074348 |
| 48 | regulation of plasminogen activation (GO:0010755) | 3.01003045 |
| 49 | DNA damage response, detection of DNA damage (GO:0042769) | 2.93493759 |
| 50 | regulation of DNA damage checkpoint (GO:2000001) | 2.91993694 |
| 51 | hyperosmotic salinity response (GO:0042538) | 2.91716226 |
| 52 | intestinal cholesterol absorption (GO:0030299) | 2.87720037 |
| 53 | regulation of complement activation (GO:0030449) | 2.87680544 |
| 54 | apoptotic DNA fragmentation (GO:0006309) | 2.86977070 |
| 55 | double-strand break repair via nonhomologous end joining (GO:0006303) | 2.86006391 |
| 56 | non-recombinational repair (GO:0000726) | 2.86006391 |
| 57 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.81068507 |
| 58 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.80676307 |
| 59 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.80302450 |
| 60 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.79929675 |
| 61 | pentose-phosphate shunt (GO:0006098) | 2.79812586 |
| 62 | glycine metabolic process (GO:0006544) | 2.79012983 |
| 63 | regulation of helicase activity (GO:0051095) | 2.78532233 |
| 64 | ATP-dependent chromatin remodeling (GO:0043044) | 2.78261439 |
| 65 | pyrimidine dimer repair (GO:0006290) | 2.77795417 |
| 66 | negative regulation of mRNA metabolic process (GO:1903312) | 2.76463572 |
| 67 | positive regulation of hemostasis (GO:1900048) | 2.73531910 |
| 68 | positive regulation of blood coagulation (GO:0030194) | 2.73531910 |
| 69 | galactose catabolic process (GO:0019388) | 2.72448375 |
| 70 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.70729107 |
| 71 | mRNA splicing, via spliceosome (GO:0000398) | 2.68612582 |
| 72 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377) | 2.68612582 |
| 73 | negative regulation of mRNA processing (GO:0050686) | 2.68314784 |
| 74 | IMP metabolic process (GO:0046040) | 2.65840009 |
| 75 | protein localization to chromosome, centromeric region (GO:0071459) | 2.65693592 |
| 76 | serine family amino acid catabolic process (GO:0009071) | 2.64467703 |
| 77 | ribonucleoprotein complex disassembly (GO:0032988) | 2.63042133 |
| 78 | serine family amino acid metabolic process (GO:0009069) | 2.62447137 |
| 79 | viral mRNA export from host cell nucleus (GO:0046784) | 2.62194765 |
| 80 | RNA splicing, via transesterification reactions (GO:0000375) | 2.62166032 |
| 81 | serine family amino acid biosynthetic process (GO:0009070) | 2.62095776 |
| 82 | alternative mRNA splicing, via spliceosome (GO:0000380) | 2.61163229 |
| 83 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.61033646 |
| 84 | metaphase plate congression (GO:0051310) | 2.60536381 |
| 85 | low-density lipoprotein particle remodeling (GO:0034374) | 2.58511819 |
| 86 | spliceosomal snRNP assembly (GO:0000387) | 2.55742021 |
| 87 | peptidyl-arginine N-methylation (GO:0035246) | 2.55263337 |
| 88 | peptidyl-arginine methylation (GO:0018216) | 2.55263337 |
| 89 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 2.54251532 |
| 90 | regulation of centriole replication (GO:0046599) | 2.52657058 |
| 91 | positive regulation of megakaryocyte differentiation (GO:0045654) | 2.51697223 |
| 92 | positive regulation of coagulation (GO:0050820) | 2.51487478 |
| 93 | nucleobase biosynthetic process (GO:0046112) | 2.50234571 |
| 94 | protein maturation by protein folding (GO:0022417) | 2.49442050 |
| 95 | negative regulation of sterol transport (GO:0032372) | 2.48420268 |
| 96 | negative regulation of cholesterol transport (GO:0032375) | 2.48420268 |
| 97 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 2.47965181 |
| 98 | protein-lipid complex assembly (GO:0065005) | 2.47893680 |
| 99 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.47745623 |
| 100 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.46574915 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.82281177 |
| 2 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.82590549 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.52214729 |
| 4 | AR_21909140_ChIP-Seq_LNCAP_Human | 3.43036598 |
| 5 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 3.36863872 |
| 6 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.35806098 |
| 7 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.96837900 |
| 8 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.90576343 |
| 9 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.70637346 |
| 10 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.69318471 |
| 11 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.61826734 |
| 12 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.61160110 |
| 13 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.58173428 |
| 14 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.53645085 |
| 15 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.52355099 |
| 16 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.38056242 |
| 17 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.36048623 |
| 18 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.33702116 |
| 19 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.31675057 |
| 20 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.30389246 |
| 21 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.27337709 |
| 22 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.19864595 |
| 23 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 2.15799642 |
| 24 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.15650711 |
| 25 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.06961526 |
| 26 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.06171840 |
| 27 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.05154465 |
| 28 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.00354564 |
| 29 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 2.00184002 |
| 30 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.99644933 |
| 31 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.99054290 |
| 32 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.97598253 |
| 33 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.97406503 |
| 34 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.85443773 |
| 35 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.82005067 |
| 36 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.79701255 |
| 37 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.79212836 |
| 38 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.76519497 |
| 39 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.74037660 |
| 40 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.73978993 |
| 41 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.73804291 |
| 42 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.73503584 |
| 43 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.73393622 |
| 44 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.72394113 |
| 45 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.70609959 |
| 46 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.69960892 |
| 47 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.69418920 |
| 48 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.66602284 |
| 49 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.63704465 |
| 50 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.62509424 |
| 51 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.55818918 |
| 52 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.51578564 |
| 53 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.49357346 |
| 54 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.49066772 |
| 55 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.48676860 |
| 56 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.46570799 |
| 57 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.42299171 |
| 58 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.40795557 |
| 59 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.40255421 |
| 60 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.38852295 |
| 61 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.37469285 |
| 62 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.33437237 |
| 63 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.32517097 |
| 64 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 1.27411363 |
| 65 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.26989655 |
| 66 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.25503002 |
| 67 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.25166827 |
| 68 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.22373961 |
| 69 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.22287090 |
| 70 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.21828187 |
| 71 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.17243166 |
| 72 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.16928294 |
| 73 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.15525867 |
| 74 | EWS_26573619_Chip-Seq_HEK293_Human | 1.15389350 |
| 75 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.15125547 |
| 76 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.14356730 |
| 77 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.13954271 |
| 78 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.13526736 |
| 79 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.10911184 |
| 80 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.07323953 |
| 81 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.06831928 |
| 82 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.06628498 |
| 83 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.05417890 |
| 84 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.04053551 |
| 85 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.03311809 |
| 86 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 1.02619415 |
| 87 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.01638192 |
| 88 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.00445423 |
| 89 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.00035184 |
| 90 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.99947952 |
| 91 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.99747024 |
| 92 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.99465579 |
| 93 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.98172196 |
| 94 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.95482247 |
| 95 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.92742121 |
| 96 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.89065174 |
| 97 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.86903943 |
| 98 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.85657040 |
| 99 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.84945254 |
| 100 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.84675576 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 3.77664958 |
| 2 | MP0009697_abnormal_copulation | 3.69436354 |
| 3 | MP0003122_maternal_imprinting | 2.95270214 |
| 4 | MP0010368_abnormal_lymphatic_system | 2.92459236 |
| 5 | MP0003111_abnormal_nucleus_morphology | 2.90809275 |
| 6 | MP0002877_abnormal_melanocyte_morpholog | 2.73269979 |
| 7 | MP0004272_abnormal_basement_membrane | 2.66454230 |
| 8 | MP0005360_urolithiasis | 2.61250192 |
| 9 | MP0003567_abnormal_fetal_cardiomyocyte | 2.56602026 |
| 10 | MP0003693_abnormal_embryo_hatching | 2.54122082 |
| 11 | MP0000537_abnormal_urethra_morphology | 2.51735583 |
| 12 | MP0001666_abnormal_nutrient_absorption | 2.45280614 |
| 13 | MP0004957_abnormal_blastocyst_morpholog | 2.41993188 |
| 14 | MP0010094_abnormal_chromosome_stability | 2.30909098 |
| 15 | MP0006054_spinal_hemorrhage | 2.30662998 |
| 16 | MP0005085_abnormal_gallbladder_physiolo | 2.30230174 |
| 17 | MP0005365_abnormal_bile_salt | 2.27327768 |
| 18 | MP0008932_abnormal_embryonic_tissue | 2.15592205 |
| 19 | MP0001915_intracranial_hemorrhage | 2.15015456 |
| 20 | MP0003077_abnormal_cell_cycle | 2.12788020 |
| 21 | MP0003806_abnormal_nucleotide_metabolis | 2.07364704 |
| 22 | MP0008058_abnormal_DNA_repair | 2.03462523 |
| 23 | MP0005623_abnormal_meninges_morphology | 2.02585876 |
| 24 | MP0001293_anophthalmia | 2.01103318 |
| 25 | MP0008875_abnormal_xenobiotic_pharmacok | 1.91858049 |
| 26 | MP0006292_abnormal_olfactory_placode | 1.85424952 |
| 27 | MP0009278_abnormal_bone_marrow | 1.84567288 |
| 28 | MP0001730_embryonic_growth_arrest | 1.80247766 |
| 29 | MP0003186_abnormal_redox_activity | 1.66963179 |
| 30 | MP0003221_abnormal_cardiomyocyte_apopto | 1.61092279 |
| 31 | MP0002233_abnormal_nose_morphology | 1.56565911 |
| 32 | MP0005084_abnormal_gallbladder_morpholo | 1.55754473 |
| 33 | MP0003315_abnormal_perineum_morphology | 1.50986031 |
| 34 | MP0002697_abnormal_eye_size | 1.48153215 |
| 35 | MP0003868_abnormal_feces_composition | 1.47600898 |
| 36 | MP0003121_genomic_imprinting | 1.45616326 |
| 37 | MP0006072_abnormal_retinal_apoptosis | 1.45343674 |
| 38 | MP0008007_abnormal_cellular_replicative | 1.44274064 |
| 39 | MP0000465_gastrointestinal_hemorrhage | 1.44048260 |
| 40 | MP0002234_abnormal_pharynx_morphology | 1.35358576 |
| 41 | MP0005380_embryogenesis_phenotype | 1.29533613 |
| 42 | MP0001672_abnormal_embryogenesis/_devel | 1.29533613 |
| 43 | MP0002092_abnormal_eye_morphology | 1.28473651 |
| 44 | MP0001697_abnormal_embryo_size | 1.25061988 |
| 45 | MP0009053_abnormal_anal_canal | 1.24486151 |
| 46 | MP0003984_embryonic_growth_retardation | 1.22161143 |
| 47 | MP0000350_abnormal_cell_proliferation | 1.20719323 |
| 48 | MP0002080_prenatal_lethality | 1.18191852 |
| 49 | MP0003252_abnormal_bile_duct | 1.17854318 |
| 50 | MP0002088_abnormal_embryonic_growth/wei | 1.17311232 |
| 51 | MP0003656_abnormal_erythrocyte_physiolo | 1.12307596 |
| 52 | MP0003195_calcinosis | 1.12195482 |
| 53 | MP0005451_abnormal_body_composition | 1.09990902 |
| 54 | MP0005391_vision/eye_phenotype | 1.05536743 |
| 55 | MP0008260_abnormal_autophagy | 1.04095202 |
| 56 | MP0000358_abnormal_cell_content/ | 1.04028057 |
| 57 | MP0003718_maternal_effect | 1.03373625 |
| 58 | MP0005058_abnormal_lysosome_morphology | 1.02388443 |
| 59 | MP0002085_abnormal_embryonic_tissue | 1.01921834 |
| 60 | MP0008789_abnormal_olfactory_epithelium | 1.01742775 |
| 61 | MP0005187_abnormal_penis_morphology | 1.00431438 |
| 62 | MP0002084_abnormal_developmental_patter | 0.99848827 |
| 63 | MP0001286_abnormal_eye_development | 0.98577818 |
| 64 | MP0002090_abnormal_vision | 0.96574118 |
| 65 | MP0002132_abnormal_respiratory_system | 0.96262678 |
| 66 | MP0000313_abnormal_cell_death | 0.94923645 |
| 67 | MP0004133_heterotaxia | 0.94793176 |
| 68 | MP0002086_abnormal_extraembryonic_tissu | 0.94171220 |
| 69 | MP0002909_abnormal_adrenal_gland | 0.94056110 |
| 70 | MP0005167_abnormal_blood-brain_barrier | 0.93853025 |
| 71 | MP0002282_abnormal_trachea_morphology | 0.92636452 |
| 72 | MP0003566_abnormal_cell_adhesion | 0.91548033 |
| 73 | MP0010329_abnormal_lipoprotein_level | 0.90904804 |
| 74 | MP0003941_abnormal_skin_development | 0.89494274 |
| 75 | MP0002138_abnormal_hepatobiliary_system | 0.89422874 |
| 76 | MP0005408_hypopigmentation | 0.88870684 |
| 77 | MP0000598_abnormal_liver_morphology | 0.88857392 |
| 78 | MP0000858_altered_metastatic_potential | 0.88489088 |
| 79 | MP0005397_hematopoietic_system_phenotyp | 0.88073132 |
| 80 | MP0001545_abnormal_hematopoietic_system | 0.88073132 |
| 81 | MP0003119_abnormal_digestive_system | 0.88068704 |
| 82 | MP0009840_abnormal_foam_cell | 0.86389153 |
| 83 | MP0009763_increased_sensitivity_to | 0.86079169 |
| 84 | MP0003937_abnormal_limbs/digits/tail_de | 0.84996248 |
| 85 | MP0005394_taste/olfaction_phenotype | 0.81343574 |
| 86 | MP0005499_abnormal_olfactory_system | 0.81343574 |
| 87 | MP0005253_abnormal_eye_physiology | 0.78117907 |
| 88 | MP0006035_abnormal_mitochondrial_morpho | 0.78106182 |
| 89 | MP0005384_cellular_phenotype | 0.77682238 |
| 90 | MP0000647_abnormal_sebaceous_gland | 0.77356149 |
| 91 | MP0005319_abnormal_enzyme/_coenzyme | 0.75050165 |
| 92 | MP0003136_yellow_coat_color | 0.74680012 |
| 93 | MP0001299_abnormal_eye_distance/ | 0.73325106 |
| 94 | MP0002736_abnormal_nociception_after | 0.72311575 |
| 95 | MP0009672_abnormal_birth_weight | 0.72283872 |
| 96 | MP0004197_abnormal_fetal_growth/weight/ | 0.71814805 |
| 97 | MP0001188_hyperpigmentation | 0.71233317 |
| 98 | MP0005464_abnormal_platelet_physiology | 0.70840883 |
| 99 | MP0003191_abnormal_cellular_cholesterol | 0.70574760 |
| 100 | MP0000609_abnormal_liver_physiology | 0.68920164 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 6.08419991 |
| 2 | Prolonged partial thromboplastin time (HP:0003645) | 4.43998222 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.63344656 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 3.56633665 |
| 5 | Multiple enchondromatosis (HP:0005701) | 3.44425005 |
| 6 | Intrahepatic cholestasis (HP:0001406) | 3.20681214 |
| 7 | Short tibia (HP:0005736) | 3.06611988 |
| 8 | Abnormality of the common coagulation pathway (HP:0010990) | 3.01319745 |
| 9 | Spastic diplegia (HP:0001264) | 2.94991763 |
| 10 | Joint hemorrhage (HP:0005261) | 2.93971202 |
| 11 | Abnormality of complement system (HP:0005339) | 2.90635812 |
| 12 | Sensorimotor neuropathy (HP:0007141) | 2.90096866 |
| 13 | Neonatal short-limb short stature (HP:0008921) | 2.88022735 |
| 14 | Dysautonomia (HP:0002459) | 2.80380849 |
| 15 | Orthostatic hypotension (HP:0001278) | 2.78379170 |
| 16 | Reduced antithrombin III activity (HP:0001976) | 2.73917003 |
| 17 | Hyperglycinemia (HP:0002154) | 2.69224947 |
| 18 | Abnormality of methionine metabolism (HP:0010901) | 2.63101406 |
| 19 | Bifid uvula (HP:0000193) | 2.62408491 |
| 20 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.59871150 |
| 21 | Menorrhagia (HP:0000132) | 2.59340948 |
| 22 | Cortical dysplasia (HP:0002539) | 2.52483123 |
| 23 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.51876048 |
| 24 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.51876048 |
| 25 | Increased serum pyruvate (HP:0003542) | 2.49387484 |
| 26 | Hyperglycinuria (HP:0003108) | 2.49021197 |
| 27 | Hypolipoproteinemia (HP:0010981) | 2.43396815 |
| 28 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.39734024 |
| 29 | Thrombophlebitis (HP:0004418) | 2.39253229 |
| 30 | Spontaneous abortion (HP:0005268) | 2.38987140 |
| 31 | Poor head control (HP:0002421) | 2.29868355 |
| 32 | Complement deficiency (HP:0004431) | 2.29170722 |
| 33 | Deviation of the thumb (HP:0009603) | 2.27311574 |
| 34 | Generalized aminoaciduria (HP:0002909) | 2.26596374 |
| 35 | Hepatocellular carcinoma (HP:0001402) | 2.23968041 |
| 36 | Abnormal autonomic nervous system physiology (HP:0012332) | 2.21989419 |
| 37 | Back pain (HP:0003418) | 2.21489278 |
| 38 | Vacuolated lymphocytes (HP:0001922) | 2.20493565 |
| 39 | Vertebral compression fractures (HP:0002953) | 2.20116926 |
| 40 | Proximal placement of thumb (HP:0009623) | 2.19090438 |
| 41 | Increased intramyocellular lipid droplets (HP:0012240) | 2.15359662 |
| 42 | Abnormality of serum amino acid levels (HP:0003112) | 2.13481257 |
| 43 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.12692761 |
| 44 | Fibular aplasia (HP:0002990) | 2.09649195 |
| 45 | Limb-girdle muscle atrophy (HP:0003797) | 2.07507219 |
| 46 | Papillary thyroid carcinoma (HP:0002895) | 2.06910463 |
| 47 | Abnormality of glycine metabolism (HP:0010895) | 2.06349947 |
| 48 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.06349947 |
| 49 | Abnormality of glycolysis (HP:0004366) | 2.03104833 |
| 50 | Deformed tarsal bones (HP:0008119) | 2.02279167 |
| 51 | Abnormality of the intrinsic pathway (HP:0010989) | 2.01929117 |
| 52 | Abolished electroretinogram (ERG) (HP:0000550) | 2.01515351 |
| 53 | Hypercholesterolemia (HP:0003124) | 2.01415714 |
| 54 | Bifid tongue (HP:0010297) | 1.97910878 |
| 55 | Tetraparesis (HP:0002273) | 1.97634477 |
| 56 | Spastic paraparesis (HP:0002313) | 1.96033045 |
| 57 | Morphological abnormality of the middle ear (HP:0008609) | 1.95437629 |
| 58 | Overlapping toe (HP:0001845) | 1.94954416 |
| 59 | Shoulder girdle muscle weakness (HP:0003547) | 1.93566651 |
| 60 | Humeroradial synostosis (HP:0003041) | 1.92984501 |
| 61 | Synostosis involving the elbow (HP:0003938) | 1.92984501 |
| 62 | Abnormal gallbladder physiology (HP:0012438) | 1.91421107 |
| 63 | Cholecystitis (HP:0001082) | 1.91421107 |
| 64 | Abnormal delivery (HP:0001787) | 1.90857938 |
| 65 | Breech presentation (HP:0001623) | 1.90820434 |
| 66 | Unilateral renal agenesis (HP:0000122) | 1.90401831 |
| 67 | Calcaneovalgus deformity (HP:0001848) | 1.90199612 |
| 68 | Hypoplastic pelvis (HP:0008839) | 1.88270129 |
| 69 | Increased muscle lipid content (HP:0009058) | 1.87236645 |
| 70 | Acanthocytosis (HP:0001927) | 1.85791137 |
| 71 | Abnormality of pain sensation (HP:0010832) | 1.85482516 |
| 72 | Impaired pain sensation (HP:0007328) | 1.85482516 |
| 73 | Myelomeningocele (HP:0002475) | 1.84473942 |
| 74 | Gonadotropin excess (HP:0000837) | 1.83427274 |
| 75 | Disinhibition (HP:0000734) | 1.82169048 |
| 76 | Nonimmune hydrops fetalis (HP:0001790) | 1.82085086 |
| 77 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.81157591 |
| 78 | Neoplasm of the colon (HP:0100273) | 1.81148309 |
| 79 | Increased mean platelet volume (HP:0011877) | 1.80757940 |
| 80 | Conjugated hyperbilirubinemia (HP:0002908) | 1.77685144 |
| 81 | Beaking of vertebral bodies (HP:0004568) | 1.77676095 |
| 82 | Purpura (HP:0000979) | 1.77255323 |
| 83 | Hypoalphalipoproteinemia (HP:0003233) | 1.76418080 |
| 84 | Capillary hemangiomas (HP:0005306) | 1.74237200 |
| 85 | Broad alveolar ridges (HP:0000187) | 1.73534361 |
| 86 | Aplasia/hypoplasia of the humerus (HP:0006507) | 1.71869412 |
| 87 | Volvulus (HP:0002580) | 1.71112589 |
| 88 | Hyperbilirubinemia (HP:0002904) | 1.70115634 |
| 89 | Cone-rod dystrophy (HP:0000548) | 1.69448407 |
| 90 | Chronic obstructive pulmonary disease (HP:0006510) | 1.69045509 |
| 91 | Obstructive lung disease (HP:0006536) | 1.69045509 |
| 92 | Exercise-induced muscle cramps (HP:0003710) | 1.68244943 |
| 93 | Abnormality of the lower motor neuron (HP:0002366) | 1.68118660 |
| 94 | Cerebral hemorrhage (HP:0001342) | 1.67932746 |
| 95 | Cerebral palsy (HP:0100021) | 1.67511486 |
| 96 | Amyloidosis (HP:0011034) | 1.63292715 |
| 97 | Fasciculations (HP:0002380) | 1.62430905 |
| 98 | Arthropathy (HP:0003040) | 1.60919641 |
| 99 | Postnatal microcephaly (HP:0005484) | 1.59915524 |
| 100 | Lipid accumulation in hepatocytes (HP:0006561) | 1.59600981 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDC7 | 3.90519590 |
| 2 | TIE1 | 3.60947922 |
| 3 | SRPK1 | 3.48968199 |
| 4 | RPS6KA4 | 3.27473989 |
| 5 | CDK12 | 2.90139220 |
| 6 | PBK | 2.85019304 |
| 7 | SCYL2 | 2.75849177 |
| 8 | BCKDK | 2.66944702 |
| 9 | BCR | 2.53430974 |
| 10 | NEK1 | 2.51785083 |
| 11 | KDR | 2.43613151 |
| 12 | TNIK | 2.37959537 |
| 13 | MKNK1 | 2.11540625 |
| 14 | PLK3 | 2.08005622 |
| 15 | STK16 | 1.95758554 |
| 16 | NEK2 | 1.90637228 |
| 17 | NTRK1 | 1.88182472 |
| 18 | PLK4 | 1.74268489 |
| 19 | ALK | 1.71698196 |
| 20 | MKNK2 | 1.64210170 |
| 21 | BMPR1B | 1.50579501 |
| 22 | TRIM28 | 1.48801473 |
| 23 | TSSK6 | 1.45267316 |
| 24 | TTK | 1.44859658 |
| 25 | NEK9 | 1.41548387 |
| 26 | BUB1 | 1.41511737 |
| 27 | BRD4 | 1.36345408 |
| 28 | LATS1 | 1.36105375 |
| 29 | CSNK1G2 | 1.31546821 |
| 30 | VRK2 | 1.24939475 |
| 31 | CSNK1G3 | 1.24552490 |
| 32 | MATK | 1.22658006 |
| 33 | PLK1 | 1.21843211 |
| 34 | CDK19 | 1.19593864 |
| 35 | CDK7 | 1.19223607 |
| 36 | WEE1 | 1.14647329 |
| 37 | CSNK1G1 | 1.13516391 |
| 38 | CDK6 | 1.11223441 |
| 39 | MOS | 1.07018716 |
| 40 | ERBB3 | 1.06033816 |
| 41 | FLT3 | 1.04299398 |
| 42 | LATS2 | 1.01818839 |
| 43 | CSNK1A1L | 0.97449684 |
| 44 | NUAK1 | 0.96937858 |
| 45 | CDK8 | 0.96733627 |
| 46 | MAP3K12 | 0.95349882 |
| 47 | ERBB4 | 0.94216039 |
| 48 | VRK1 | 0.92866879 |
| 49 | EIF2AK3 | 0.89078005 |
| 50 | DYRK3 | 0.86307775 |
| 51 | DAPK1 | 0.84159113 |
| 52 | ZAK | 0.83850399 |
| 53 | ATR | 0.82743194 |
| 54 | PLK2 | 0.82635740 |
| 55 | PAK4 | 0.80007088 |
| 56 | CDK4 | 0.78234538 |
| 57 | SIK3 | 0.78150850 |
| 58 | AURKB | 0.74481517 |
| 59 | STK3 | 0.72680807 |
| 60 | STK24 | 0.72468043 |
| 61 | CDK18 | 0.70387531 |
| 62 | BRSK2 | 0.70028301 |
| 63 | MAP3K11 | 0.69900898 |
| 64 | CDK11A | 0.69281446 |
| 65 | AURKA | 0.67816712 |
| 66 | PDGFRA | 0.67808342 |
| 67 | PNCK | 0.67564936 |
| 68 | FGR | 0.66800977 |
| 69 | CDK14 | 0.64433857 |
| 70 | CDK15 | 0.63244001 |
| 71 | GRK7 | 0.60448416 |
| 72 | ABL2 | 0.59495098 |
| 73 | CSNK2A2 | 0.58046818 |
| 74 | CHEK2 | 0.57569476 |
| 75 | CSNK1D | 0.57391477 |
| 76 | CHEK1 | 0.57164507 |
| 77 | EIF2AK1 | 0.57071509 |
| 78 | DYRK1B | 0.56240183 |
| 79 | CSNK2A1 | 0.56171644 |
| 80 | MAP2K7 | 0.54541649 |
| 81 | ATM | 0.54272137 |
| 82 | CSNK1E | 0.53759269 |
| 83 | MAP4K2 | 0.53399479 |
| 84 | CDK9 | 0.53377168 |
| 85 | TGFBR2 | 0.50456078 |
| 86 | YES1 | 0.48982471 |
| 87 | BMPR2 | 0.48722485 |
| 88 | CSF1R | 0.45732868 |
| 89 | STK38L | 0.42875439 |
| 90 | CDK2 | 0.40818997 |
| 91 | CDK1 | 0.40700883 |
| 92 | EIF2AK2 | 0.39343425 |
| 93 | RIPK1 | 0.38404437 |
| 94 | PIK3CG | 0.37987139 |
| 95 | FGFR1 | 0.36815313 |
| 96 | EGFR | 0.34517746 |
| 97 | RPS6KA5 | 0.32828938 |
| 98 | PDK2 | 0.29021475 |
| 99 | IGF1R | 0.27506518 |
| 100 | PRKACB | 0.27362266 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 2.73976924 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 2.63647136 |
| 3 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.53936951 |
| 4 | Spliceosome_Homo sapiens_hsa03040 | 2.50893695 |
| 5 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.44492305 |
| 6 | Mismatch repair_Homo sapiens_hsa03430 | 2.39454911 |
| 7 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.39085314 |
| 8 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.38499586 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.24306850 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.13539678 |
| 11 | Base excision repair_Homo sapiens_hsa03410 | 2.09684409 |
| 12 | Protein export_Homo sapiens_hsa03060 | 2.08877303 |
| 13 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.97004808 |
| 14 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.92786099 |
| 15 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.91964199 |
| 16 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.86097072 |
| 17 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.85150170 |
| 18 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.83654388 |
| 19 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.78415370 |
| 20 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.75213867 |
| 21 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.72714284 |
| 22 | Carbon metabolism_Homo sapiens_hsa01200 | 1.72166892 |
| 23 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.71042593 |
| 24 | RNA transport_Homo sapiens_hsa03013 | 1.69277541 |
| 25 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.67670621 |
| 26 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.62156181 |
| 27 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.60286013 |
| 28 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.59876012 |
| 29 | Peroxisome_Homo sapiens_hsa04146 | 1.59329370 |
| 30 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.53235733 |
| 31 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.51127018 |
| 32 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.41626882 |
| 33 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.41255117 |
| 34 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.31224230 |
| 35 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.29329958 |
| 36 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.25915683 |
| 37 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.24102950 |
| 38 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.22804761 |
| 39 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.22109089 |
| 40 | Cell cycle_Homo sapiens_hsa04110 | 1.21857875 |
| 41 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.21331231 |
| 42 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.20584556 |
| 43 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.20048884 |
| 44 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.17605586 |
| 45 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.16367529 |
| 46 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.15234893 |
| 47 | RNA polymerase_Homo sapiens_hsa03020 | 1.08737027 |
| 48 | Retinol metabolism_Homo sapiens_hsa00830 | 1.07387589 |
| 49 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.06769095 |
| 50 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.05711166 |
| 51 | Sulfur relay system_Homo sapiens_hsa04122 | 1.04085080 |
| 52 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.03782712 |
| 53 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.02638908 |
| 54 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.01576125 |
| 55 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.00261528 |
| 56 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.99106180 |
| 57 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.98678127 |
| 58 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.95424780 |
| 59 | Asthma_Homo sapiens_hsa05310 | 0.93105880 |
| 60 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.88559305 |
| 61 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.87543663 |
| 62 | Homologous recombination_Homo sapiens_hsa03440 | 0.86283661 |
| 63 | Galactose metabolism_Homo sapiens_hsa00052 | 0.85661996 |
| 64 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.84984834 |
| 65 | Other glycan degradation_Homo sapiens_hsa00511 | 0.84489579 |
| 66 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.84269371 |
| 67 | RNA degradation_Homo sapiens_hsa03018 | 0.81734079 |
| 68 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.74994312 |
| 69 | Legionellosis_Homo sapiens_hsa05134 | 0.72609426 |
| 70 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.72061878 |
| 71 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.69930740 |
| 72 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.67096921 |
| 73 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.62872773 |
| 74 | Metabolic pathways_Homo sapiens_hsa01100 | 0.59830967 |
| 75 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.58732883 |
| 76 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.57416047 |
| 77 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.51786497 |
| 78 | Purine metabolism_Homo sapiens_hsa00230 | 0.50217490 |
| 79 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.49660959 |
| 80 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.48811251 |
| 81 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.47136964 |
| 82 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.46473684 |
| 83 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.46135916 |
| 84 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.43997757 |
| 85 | Allograft rejection_Homo sapiens_hsa05330 | 0.42306887 |
| 86 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.42299945 |
| 87 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.42274609 |
| 88 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.40715060 |
| 89 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.39827674 |
| 90 | Salmonella infection_Homo sapiens_hsa05132 | 0.38692042 |
| 91 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.37775111 |
| 92 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.36814019 |
| 93 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.36470438 |
| 94 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.36401318 |
| 95 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.35851369 |
| 96 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.33326669 |
| 97 | Lysosome_Homo sapiens_hsa04142 | 0.31682910 |
| 98 | Lysine degradation_Homo sapiens_hsa00310 | 0.30368449 |
| 99 | Viral myocarditis_Homo sapiens_hsa05416 | 0.30195981 |
| 100 | Shigellosis_Homo sapiens_hsa05131 | 0.27055219 |

